Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Caribou Biosciences Inc (NASDAQ:CRBU) Posts Mixed Q2 2025 Earnings with Revenue Beat but Wider Loss
Via Chartmill
Tickers CRBU
FRACTYL HEALTH INC (NASDAQ:GUTS) Reports Wider-Than-Expected Q2 2025 Loss Amid Clinical Progress
Via Chartmill
Tickers GUTS
Rigetti Computing Inc (NASDAQ:RGTI) Q2 2025 Earnings Report: Revenue and EPS Miss, Shares Drop Post-Announcement
Via Chartmill
Topics Earnings
Tickers RGTI
Exposures Financial
Lyell Immunopharma Inc (NASDAQ:LYEL) Reports Q2 2025 Earnings Beat with Clinical Progress on LYL314
Via Chartmill
Topics Earnings
Tickers LYEL
Exposures Financial
FATE THERAPEUTICS INC (NASDAQ:FATE) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss
Via Chartmill
Tickers FATE
Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027
Via Chartmill
Tickers MAZE
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Via Chartmill
Tickers CUE
Exposures Product Safety
Urgently Inc (NASDAQ:ULY) Q2 2025 Earnings: Revenue Meets Targets but EPS Falls Short
Via Chartmill
Tickers ULY
QuickLogic Corp (NASDAQ:QUIK) Misses Q2 2025 Revenue and EPS Estimates, Shares Drop Nearly 10%
Via Chartmill
Topics Earnings
Tickers QUIK
Exposures Financial
SoundThinking Inc (NASDAQ:SSTI) Misses Q2 2025 Revenue and EPS Estimates, Reaffirms Full-Year Guidance
Via Chartmill
Tickers SSTI
Prairie Operating Co. (NASDAQ:PROP) Q2 2025 Earnings Report: Revenue and EPS Fall Short, Market Shows Mixed Reaction
Via Chartmill
Topics Earnings
Tickers PROP
Exposures Financial
SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges
Via Chartmill
Tickers SLS
Pharvaris NV (NASDAQ:PHVS) Reports Wider Q2 2025 Loss, Highlights Clinical Trial Progress
Via Chartmill
Tickers PHVS
VTV Therapeutics Inc-CL A (NASDAQ:VTVT) Reports Wider Q2 2025 Loss Amid Clinical-Stage Progress
Via Chartmill
Tickers VTVT
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss
Via Chartmill
Tickers PROK
Exposures Product Safety
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Mixed Q2 2025 Results with Record Revenue but Narrow EPS Miss
Via Chartmill
Tickers CLPT
Rekor Systems Inc (NASDAQ:REKR) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected
Via Chartmill
Tickers REKR
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring
Via Chartmill
Tickers ORIC
OnKure Therapeutics Inc-A (NASDAQ:OKUR) Reports Q2 2025 Earnings Beat with Narrower-Than-Expected Loss
Via Chartmill
Topics Earnings
Tickers OKUR
Exposures Financial
Editas Medicine Inc (NASDAQ:EDIT) Reports Mixed Q2 2025 Earnings: Revenue Beat but Wider Loss
Via Chartmill
Tickers EDIT
Astria Therapeutics Inc (NASDAQ:ATXS) Reports Narrower-Than-Expected Q2 2025 Loss and Strong Cash Runway
Via Chartmill
Tickers ATXS
Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
Via Chartmill
Tickers MGX
GRAIL INC (NASDAQ:GRAL) Reports Mixed Q2 2025 Earnings: Revenue Misses, Loss Narrows
Via Chartmill
Tickers GRAL
INOVIO PHARMACEUTICALS INC (NASDAQ:INO) Reports Q2 2025 Results: Revenue at $0.0, EPS Loss of $0.61 Amid 4.7% After-Hours Drop
Via Chartmill
Tickers INO
CAVA GROUP INC (NYSE:CAVA) Reports Mixed Q2 2025 Results with Revenue Miss and EPS Beat
Via Chartmill
Tickers CAVA
Marchex Inc. (NASDAQ:MCHX) Reports Mixed Q2 2025 Results with Revenue Miss and Adjusted EBITDA Growth
Via Chartmill
Tickers MCHX
KinderCare Learning Cos Inc (NYSE:KLC) Reports Mixed Q2 2025 Results with Revenue Miss and Lowered Guidance
Via Chartmill
Tickers KLC
Annovis Bio (NYSE:ANVS) Reports Narrower Q2 2025 Loss, Advances Alzheimer's and Parkinson's Trials
Via Chartmill
Tickers ANVS
PSQ Holdings Inc (NYSE:PSQH) Reports Q2 2025 Revenue Miss Amid Strategic Fintech Pivot
Via Chartmill
Tickers PSQH
SOUTHLAND HOLDINGS INC (NYSEARCA:SLND) Posts Mixed Q2 2025 Results with Improved Margins Despite Revenue Decline
Via Chartmill
Tickers SLND
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.